NOS2 and Alzheimer disease: The SARs outlined provided an insight into the interactions between iNOS and a new class of the most potent NO inhibitors (9c, 9q) to facilitate the further structural modification of this compound class, and two derivatives 9q and 9o have potential as dual-role therapeutic agents for AD treatment.